Category: Biotech

January 18, 2022

Developing drugs is a capital-intensive activity, and never more so than when a biotech company wants to move from preclinical development to more expensive clinical trials. Early on, there are often angel investments and/or academic or government grants, but the […]

January 12, 2022

The momentum of biotech and biopharma companies is on the rise in anticipation of a new wave of emerging therapies moving through the industry’s development pipeline. In addition, the COVID-19 pandemic highlighted the importance of companies that can react quickly […]

January 7, 2022

Merck is taking a deep dive into complex proteins with the help of artificial-intelligence-powered drug discovery company Absci. The two companies have signed a research collaboration for up to three targets in a deal worth up to $610 million in […]

January 6, 2022

Eikon Therapeutics, the drug discovery startup with a former Merck & Co. research chief at the helm, has appointed a pantheon of biotech veterans on its quest to take its live-cell imaging platform to the next level. The biotech unveiled […]

December 28, 2021

Anton Middelberg, PhD, deputy vice-chancellor and vice-president of research at the University of Adelaide in Australia, believes industry reluctance to go continuous reflects the traditional focus on batch-mode production and, in some areas, the technical challenges. “The complexity in continuous […]

December 22, 2021

We thought we’d finally get to see what a post-pandemic world looked like in 2022, but thanks to omicron, it seems we’re in for another round. Biotech has been shaped by the pandemic in ways that may be permanent, just […]

December 7, 2021

Gary Glick, a chemist and well-known biotech entrepreneur, has raised more than $200 million to launch the latest company aiming to harness advances in medicinal chemistry to invent new drugs for cancer and inflammatory diseases. Called Odyssey Therapeutics, the startup […]

December 1, 2021

The momentum of biotech and biopharma companies is on the rise in anticipation of a new wave of emerging therapies moving through the industry’s development pipeline. In addition, the COVID-19 pandemic highlighted the importance of companies that can react quickly […]

November 24, 2021

Large biomanufacturing facilities, including some that may be involved in producing COVID-19 vaccines and drugs, are being targeted by a malware threat that seems to have an unprecedented level of sophistication, according to a cybersecurity group. The Bioeconomy Information Sharing […]

November 9, 2021

Long before we knew how they did it, human cells had refined the process for making proteins, the microscopic workers needed for pretty much everything our bodies do. First, a special enzyme finds the instructions for a protein in our […]

October 12, 2021

In October, Chetan Goudar, PhD, vice president at Amgen process development, and his colleagues wrote in Current Opinion in Biotechnology: “Rapid technological advances have significantly improved the capability, versatility, and robustness of mass spectrometers which has led to them playing […]

September 20, 2021

Researchers from the Université de Montpellier, France, and the University of Pittsburgh, have published a study (“Mycobacteriophage-antibiotic therapy promotes enhanced clearance of drug-resistant Mycobacterium abscessus”) in Disease Models & Mechanisms that describes the antibacterial effects of treating infections caused by […]